Falloposcope and method for ovarian cancer detection
US10939864B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Feb 3, 2016 |
| Grant date | Mar 9, 2021 |
| Priority date | — |
| Expiry date | Sep 3, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61B5/0075
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A falloposcope is described, as is a method of screening a patient for fallopian tube and/or ovarian cancer with the Falloposcope. The falloposcope has an optical imaging subsystem capable of performing optical and fluorescence imaging, and an optical coherence tomography (OCT) channel, with a diameter of about 0.7 millimeter. The method includes inserting the falloposcope through a lumen of vagina, cervix, uterus, and fallopian tube such that a tip of the falloposcope is in proximity to a first fallopian tube or ovary of the patient; providing at least one fluorescence stimulus wavelength through an illumination fiber of the falloposcope, while imaging light at one or more fluorescence emission wavelengths through a coherent fiber bundle to form fluorescence emissions images; and determining suspect tissue from the fluorescence emission images. The OCT channel is also used to examine abnormalities in in-vivo female tissue, both to determine suspect tissue and analyze suspect abnormal tissue from fluorescence observations.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.